Understand the key differences between gene therapy and stem cell transplant clinical trials and research opportunities
Modifies genes to treat or prevent disease. CRISPR-based approaches and viral vector delivery are advancing rapidly. Still largely experimental in clinical trials.
Replaces diseased bone marrow with healthy stem cells. Well-established for blood cancers. Both autologous and allogeneic approaches have active research.
Gene therapy targets the root genetic cause but is early-stage. Stem cell transplant is proven for blood cancers but carries significant risks (GVHD, infection).
Search our database of 29,000+ UK clinical trials matched to your condition and profile
Browse Disease PathwaysData sourced from ClinicalTrials.gov. Trial counts are approximate and updated regularly.
TrialConnect is a trading name of Clinical Vendor Compare Limited.